Abstract

We generalize the notion of λ-superstrings, presented in a previous paper, to the notion of weighted λ-superstrings. This generalization entails an important improvement in the applications to vaccine designs, as it allows epitopes to be weighted by their immunogenicities. Motivated by these potential applications of constructing short weighted λ-superstrings to vaccine design, we approach this problem in two ways. First, we formalize the problem as a combinatorial optimization problem (in fact, as two polynomially equivalent problems) and develop an integer programming (IP) formulation for solving it optimally. Second, we describe a model that also takes into account good pairwise alignments of the obtained superstring with the input strings, and present a genetic algorithm that solves the problem approximately. We apply both algorithms to a set of 169 strings corresponding to the Nef protein taken from patiens infected with HIV-1. In the IP-based algorithm, we take the epitopes and the estimation of the immunogenicities from databases of experimental epitopes. In the genetic algorithm we take as candidate epitopes all 9-mers present in the 169 strings and estimate their immunogenicities using a public bioinformatics tool. Finally, we used several bioinformatic tools to evaluate the properties of the candidates generated by our method, which indicated that we can score high immunogenic λ-superstrings that at the same time present similar conformations to the Nef virus proteins.

Highlights

  • Infectious and transmissible diseases cause deaths of millions of people every year

  • Weighted lambda superstrings applied to vaccine design pairwise alignments of the obtained superstring with the host strings, and presented a heuristic approach based on a multi-objective genetic algorithm

  • By considering the alignment as a target to optimize by our algorithm, the weighted λ-superstrings obtained by using the genetic algorithm correspond to pseudoproteins structurally similar to the original ones taken from the patients, instead of being just epitope aggregates, opening the doors to possible improvements in the current methodology of epitope vaccine design

Read more

Summary

Introduction

Infectious and transmissible diseases cause deaths of millions of people every year. The best immunological measures to prevent such diseases are vaccines. The main efforts of immunologists are focused towards improving our predictions of effective epitopes that would confer protection against pathogens [1] and towards enhancing our ability to select appropriate epitopes for inclusion in an efficient vaccine [2]. Protective immunity requires humoral or cellular immunity depending on the pathogen.

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call